Assignee
GENEVIVE INC
US·4 granted patents·2 pending applications·0 citations·filing 2020–2023
Top patents by PatentIndex Score
6 records- 0181US12168677B2Proteins for the treatment of epithelial barrier function disordersGENEVIVE INC·Filed 2023·Granted Dec 17, 2024·0 cites·18 claims
- 0273US12371456B2Proteins for the treatment of epithelial barrier function disordersGENEVIVE INC·Filed 2022·Granted Jul 29, 2025·0 cites·14 claims
- 0372US12186364B2Proteins for the treatment of epithelial barrier function disordersGENEVIVE INC·Filed 2022·Granted Jan 7, 2025·0 cites·3 claims
- 0467US2024115625A1Roseburia hominis, eubacterium eligens, and combinations thereof as biotherapeuticsGENEVIVE INC·Filed 2023·Application pending·0 cites
- 0553US2024317816A1Peptides for immunotherapyGENEVIVE INC·Filed 2022·Application pending·0 cites
- 0650US12168676B2Microbially derived peptides and proteins for immunotherapyGENEVIVE INC·Filed 2020·Granted Dec 17, 2024·0 cites·10 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →